Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients
Nadia Galizzi, Andrea Poli, Laura Galli, Camilla Muccini, Andrea Mastrángelo, Raffaele Dell’Acqua, Myriam Maillard, Simona Bossolasco, Paola Cinque, Adriano Lazzarin, Antonella Castagna, Nicola Gianotti
Topics & Concepts
DolutegravirRilpivirineMedicineLamivudineRegimenInternal medicineIncidence (geometry)Drug resistanceRetrospective cohort studyGastroenterologyHuman immunodeficiency virus (HIV)Viral loadReverse-transcriptase inhibitorVirologyAntiretroviral therapyVirusBiologyHepatitis B virusOpticsPhysicsMicrobiologyHIV/AIDS drug development and treatmentHIV Research and TreatmentPneumocystis jirovecii pneumonia detection and treatment